Page last updated: 2024-10-24

calmidazolium and Abnormalities, Drug-Induced

calmidazolium has been researched along with Abnormalities, Drug-Induced in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smedley, M1
Stanisstreet, M1

Other Studies

1 other study available for calmidazolium and Abnormalities, Drug-Induced

ArticleYear
Effect of the calmodulin inhibitor R24571 (calmidazolium) on rat embryos cultured in vitro.
    Experientia, 1984, Sep-15, Volume: 40, Issue:9

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Calmodulin; Culture Techniques; Embry

1984